Southeast Asia has seen her fair share of Nipah virus outbreaks. How do we stay ahead of the enemy? by Dr Sunny Himansu The recent use and success of messenger RNA (mRNA) vaccines in protecting...
A novel machine learning method can identify past infections using unprecedentedly small datasets retrieved from T-cell receptors and has the potential to enhance the understanding of how the immune...
The new form of IL-12 has been demonstrated to overcome the limitations of current treatments, presenting a safer and more effective therapy for cancer patients. Cytokines are small proteins that...
This artificial cornea would require no co-implantation of donor corneas, making it an ideal option for treating patients with corneal blindness. On December 7, 2021, MIOK Keratoprosthesis was...
A recent study pinpoints the precise molecular targets of organ transplant rejection. This discovery prompted the development of tools to identify and characterise donor-reactive T cells in the...
Immunologists have uncovered the underlying mechanisms of IgA antibodies in neutralising viruses - through the activation of NETosis cell death and formation of sticky “spider-web” traps that...
University of South Australia cancer researcher, Dr Nirmal Robinson, working with a team in Naples, has found evidence in animal models that the beta-blocker Propranolol helps suppress the spread of...
Researchers from Singapore find that maternal antibodies responsible for triggering allergic reactions can cross the placenta and enter a developing foetus, hinting at why infants exhibit allergies...
A collaborative study among medical professionals and scientists from the National Centre for Infectious Diseases (NCID) and A*STAR’s Singapore Immunology Network (SIgN) unveiled four crucial...
Immunologists in Japan propose that massive release of proinflammatory cytokines lead to the development of COVID-19 in patients. Acute Respiratory Distress Syndrome (ARDS) is a life-threatening...
Scientists at the Hong Kong University of Science and Technology (HKUST) identified potential vaccine targets for SARS-CoV-2 coronavirus. Early 2020 saw the emergence and spread of COVID-19 across 28...
Mundipharma enters into partnership with Samsung Bioepis to broaden reach of biosimilars to Taiwan and Hong Kong. Mundipharma, an independent network of companies announced on 13th January 2020 that...
